ArticlePoultry science2026
Lactobacillus salivarius D5 improves growth performance and immune function in broilers by reducing Escherichia coli abundance and regulating the gut microbiota.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormal proliferation of Escherichia coli (E. coli) in the intestinal tract of broilers can lead to diseases, resulting in severe economic losses. Probiotics have attracted increasing attention for their beneficial effects, such as antagonizing pathogenic bacteria and improving gut health. This study aimed to screen probiotic strains capable of inhibiting E. coil and investigate their effects on broiler growth performance and overall health. Based on evaluations of antibacterial activity, stress tolerance, and adhesion capacity in vitro, Lactobacillus salivarius D5 (L. salivarius D5), Lactobacillus agilis IM7 (L. IM7), and Lactobacillus johnsonii DM11 (L. johnsonii DM11) were selected for feeding trials in broilers. At the conclusion of the 42-day feeding period, L. salivarius D5 significantly increased the average daily gain (ADG) of broilers (P < 0.05) and exhibited a trend toward reducing the feed conversion rate (FCR) (P = 0.053). Further analysis revealed that D5 significantly increased the spleen index and serum IgM levels, while markedly promoting villus development in the jejunum and ileum, as well as the expression of intestinal IL-10 (P < 0.05). Additionally, D5 also reshaped the cecal microbiota structure, increasing the Firmicutes/Bacteroidetes ratio and the abundance of beneficial genera (such as Alistipes and Lactobacillus), while concurrently reducing the abundance of potential pathogenic bacteria (such as Petroclostridium) in the intestine. Results from 16S rRNA sequencing and absolute quantification consistently demonstrated that D5 effectively inhibited E. coli proliferation in the intestine, particularly in the duodenum (P < 0.05). In conclusion, L. salivarius D5 enhanced broiler growth performance by suppressing E. coli, improving microbial balance, strengthening immune function, and promoting intestinal development. These findings suggest that L. salivarius D5 holds potential as a feed additive in broiler production.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.